Azenta's 12.0% revenue growth in 2026Q3 to $161.2M suggests a potential demand inflection, yet operating income remains negative at -$2.6M margin, indicating fixed costs still outpace scaling. The fortress balance sheet (D/E 0.04, $189.7M cash) provides strate...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 4, 2026 | $0.16+40.6% vs $0.11 | $161M+8.0% vs $149M |
Q2 2026 May 6, 2026 | -$0.04-140.0% vs $0.10 | $145M-2.4% vs $148M |
Q1 2026 Feb 4, 2026 | $0.09-18.2% vs $0.11 | $149M+1.1% vs $147M |
Q4 2025 Nov 21, 2025 | $0.21+10.8% vs $0.19 | $159M+1.9% vs $156M |
Azenta, Inc. (NASDAQ: AZTA - Get Free Report) has been assigned an average recommendation of "Hold" from the seven ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have issued a buy recommendation on the
Jupiter Topco LLC bought a new stake in Azenta, Inc. (NASDAQ: AZTA) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 17,049 shares of the company's stock, valued at approximately $435,000. Several other institutional investors and hedge funds have also recently bought and
BURLINGTON, Mass., Sept. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has received repayment in full, prior to maturity, of the $35 million secured vendor loan extended in connection with the previously announced sale of B Medical Systems S.
BlackRock Inc. bought a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 7,529,450 shares of the company's stock, valued at approximately $192,152,000. BlackRock Inc. owned about
Benchmark AZTA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Azenta, Inc. (AZTA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $34.28 | $1.58B | -28.10 | 3.55% | -9.39% | -3.19% | — | |
| $89.95 | $10.89B | -145.08 | 24.12% | -7.35% | -4.85% | — | |
| $38.07 | $1.86B | -152.28 | 16.97% | 49.06% | 13.29% | — | |
| $52.60 | $1.05B | 18.01 | 6.77% | 16.28% | 29.03% | — | |
| $36.47 | $670.97M | 8.38 | -0.2% | 26.69% | 506.78% | — | |
| $43.69 | $9.01B | 21.42 | 5.65% | 19.49% | 11.6% | — |
Azenta, Inc. (AZTA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Azenta, Inc. (AZTA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 11, 2026·SEC
Aug 4, 2026·SEC
Jul 8, 2026·SEC
Get notified when AZTA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Azenta, Inc. (AZTA) stock FAQ — growth, dividends, profitability & financials explained
Azenta, Inc. (AZTA) reported $613.8M in revenue for fiscal year 2025. This represents a 579% increase from $90.4M in 1996.
Azenta, Inc. (AZTA) grew revenue by 3.6% over the past year. Growth has been modest.
Azenta, Inc. (AZTA) reported a net loss of $122.9M for fiscal year 2025.
Azenta, Inc. (AZTA) has a return on equity (ROE) of -3.2%. Negative ROE indicates the company is unprofitable.
Azenta, Inc. (AZTA) generated $9.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
